NCT03809026

Brief Summary

Couples referred for microdissection-TESE (m-TESE) due to Klinefelter's syndrome, maturation stop in the spermatogenesis, or failed retrieval of testicular spermatozoa by conventional techniques with needle or TruCut are included. The women are stimulated with FSH in IVF protocols and the aspirated oocytes vitrified with usual applied techniques. Fresh sperm retrieved by micro-TESE are used for fertilization of the warmed oocytes. when it is not possible to obtain testicular sperm, the couples are offered fertilization with warmed oocytes. Fertilization, cleavage, implantation and pregnancy rates using sperm from the patients versus from sperm donors will be compared.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2015

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

January 16, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 18, 2019

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

November 2, 2023

Status Verified

November 1, 2023

Enrollment Period

8.3 years

First QC Date

January 16, 2019

Last Update Submit

November 1, 2023

Conditions

Keywords

Azoospermiamicro-TESEKlinefelter's syndromeCryptorchidismVitrified oocytes

Outcome Measures

Primary Outcomes (3)

  • Cleavage rate

    Measurement of % of cleavage among the warmed oocytes

    six years

  • Pregnancy rate

    Measurement of serum-hCG and ultrasonography at gestation age week 7

    six years

  • Fertilization rate

    Measurement of % of fertilization among the warmed oocytes

    six years

Secondary Outcomes (1)

  • Implantation rate

    six years

Study Arms (2)

Study group

Couples where the men have Klinefelter's syndrome, maturation stop in the spermatogenesis or failed retrieval of testicular sperm by conventional techniques with needle or TruCut, and where testicular sperm could be obtained by micro-TESE.

Control group

Couples as in the study group, but where testicular sperm could not be obtained by micro-TESE. The oocytes therefore must be fertilized using donor sperm.

Eligibility Criteria

Age18 Years - 100 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsActually we treat infertile couples with a man and a woman, but the variable originates from the man.
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Men referred to micro-TESE due to Klinefelter's syndrome, maturation stop in the spermatogenesis, or failed sperm retrieval using conventional needles or TruCut.

You may qualify if:

  • Couples referred for micro-TESE

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre of Andrology & Fertility Clinic, Department D, Odense University Hospital

Odense, DK-5000, Denmark

RECRUITING

Centre of Andrology & Fertility Clinic, Odense University Hospital

Odense, DK-5000, Denmark

RECRUITING

MeSH Terms

Conditions

Azoospermia, NonobstructiveAzoospermiaKlinefelter SyndromeCryptorchidism

Condition Hierarchy (Ancestors)

Infertility, MaleGenital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital DiseasesSex Chromosome Disorders of Sex DevelopmentDisorders of Sex DevelopmentUrogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsSex Chromosome DisordersChromosome DisordersCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, InbornGonadal DisordersEndocrine System DiseasesHypogonadismTesticular Diseases

Central Study Contacts

Jens Fedder, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, MD, PhD

Study Record Dates

First Submitted

January 16, 2019

First Posted

January 18, 2019

Study Start

September 1, 2015

Primary Completion

December 31, 2023

Study Completion

June 30, 2024

Last Updated

November 2, 2023

Record last verified: 2023-11

Locations